Home
Home » companies

Eli Lilly

Analysis: Alimta patent seen as Lilly's "wild card"

Analysis: Alimta patent seen as Lilly's "wild card"
Yahoo/Reuters

Top Alzheimer's Missteps of 2012

Top Alzheimer's Missteps of 2012
Motley Fool

Viagra vs. Cialis: Little Blue Pill Is Losing Big

Viagra vs. Cialis: Little Blue Pill Is Losing Big
Bloomberg

2 BioPharma Stocks To Consider: Data & Facts

2 BioPharma Stocks To Consider: Data & Facts
Motley Fool

Does Lilly's Lineup Make the Grade?

Does Lilly's Lineup Make the Grade?
Motley Fool

Will This Pharmaceutical Rise in 2013?

Will This Pharmaceutical Rise in 2013?
m

SEC Levels $29.4 Million Fine Against Lilly for FCPA Violations

SEC Levels $29.4 Million Fine Against Lilly for FCPA Violations
Motley Fool

There is Life After Patent Expirations: Why Pfizer and Lilly Stocks Rebounded

There is Life After Patent Expirations: Why Pfizer and Lilly Stocks Rebounded
Forbes

Oncolytics Biotech: What Is All The Excitement About?

Oncolytics Biotech: What Is All The Excitement About?
Seeking Alpha

Will What Happened to Lilly in 2012 Stay in 2012?

Will What Happened to Lilly in 2012 Stay in 2012?
Motley Fool